June 2018—Medtronic received FDA approval for its Guardian Connect continuous glucose monitoring system for people with diabetes ages 14 to 75 years. The Guardian Connect system is a smart standalone CGM system that can alert patients of potential high or low glucose events up to 60 minutes in advance. The Guardian Connect system was proven in a clinical study to accurately alert patients of 98.5 percent of hypoglycemic events. Care partners can use the system to track glucose levels in real time or receive text alerts. The system’s Sugar.IQ app analyzes how a person’s glucose levels respond to food intake, insulin dosages, daily routines, and other factors. With the Guardian Connect system, the Sugar.IQ assistant can reveal difficult to determine patterns into personalized, actionable insights to help users keep glucose levels in their target range.